Use of Biomaterials as Desensitizer Agents
Dentin Sensitivity
About this trial
This is an interventional treatment trial for Dentin Sensitivity focused on measuring nano-hydroxyapatite
Eligibility Criteria
Inclusion Criteria:
• patients will be considered suitable for the study if they had sensitive teeth showing abrasion, erosion, or recession with the exposure of the cervical dentine;
Exclusion Criteria:
- teeth with subjective or objective evidence of carious lesions, pulpitis, restorations, premature contact, cracked enamel, active periapical infection, or which had received periodontal surgery or root-planning up to 6 months prior to the investigation will be excluded from the study
- professional desensitizing therapy during the previous 3 months, or use of desensitizing toothpaste in the last 6 weeks.
- Patients will be also excluded if they will be under significant medication that could interfere with pain perception (e.g., antidepressants, anti-inflammatory drugs, sedatives, and muscle relaxants).
Sites / Locations
- Complex Operative Unit of Dentistry
Arms of the Study
Arm 1
Experimental
Patients with dentin hypersensitivity
Patients with evident clinical signs of dentin hypersensitivity The following dental materials will be used following the manufacturers' instructions: Cavex Bite&White ExSense; Kuraray Teethmate™ Desensitizer; Ghimas Dentin Desensitizer. In view of the treatment with the desensitizing agents, teeth were randomly assigned into four groups. The application of the materials will be made only once. The effectiveness will be evaluated: immediately after application and after 1, 4, 12 weeks.